Equities

Pharma Foods International Co Ltd

2929:TYO

Pharma Foods International Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)887.00
  • Today's Change6.00 / 0.68%
  • Shares traded231.30k
  • 1 Year change-43.03%
  • Beta2.2308
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Jul 31 2024202420232022
ASSETS
Cash And Short Term Investments15,66616,3068,845
Total Receivables, Net4,2944,5827,425
Total Inventory6,7176,0536,066
Prepaid expenses------
Other current assets, total5985891,177
Total current assets27,27527,53023,513
Property, plant & equipment, net4,6094,4044,458
Goodwill, net124197270
Intangibles, net534135
Long term investments3,0372,5141,572
Note receivable - long term------
Other long term assets1,1241,1511,311
Total assets36,57336,23231,159
LIABILITIES
Accounts payable1,2509371,176
Accrued expenses727270
Notes payable/short-term debt14,90017,40015,400
Current portion long-term debt/capital leases760965771
Other current liabilities, total6,1815,0005,378
Total current liabilities23,16324,37422,795
Total long term debt1,2311,752718
Total debt16,89120,11716,889
Deferred income tax------
Minority interest----2.00
Other liabilities, total594476572
Total liabilities24,98826,60224,087
SHAREHOLDERS EQUITY
Common stock2,0432,0432,042
Additional paid-in capital1,8141,8141,820
Retained earnings (accumulated deficit)8,3565,7923,300
Treasury stock - common(1194)(343)(138)
Unrealized gain (loss)56632446
Other equity, total----2.00
Total equity11,5859,6307,072
Total liabilities & shareholders' equity36,57336,23231,159
Total common shares outstanding282929
Treasury shares - common primary issue1.010.230.05
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.